| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.1 |